Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings outcomes as we speak.
Reported gross sales elevated 5.2% year-over-year to $22.5 billion.
GAAP earnings decreased 37.5% to $2.7 billion whereas EPS fell 34% to $1.11 in comparison with final 12 months. Adjusted EPS was down 9% to $2.42.
For full-year 2024, JNJ expects reported gross sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.
(This story can be up to date shortly with an infographic)
China's Commerce Minister Wang Wentao held a press conference on May 23, 2026, at the end of the APEC trade...
I know everybody is excited about the PDT rule change coming in June. It’s going to unshackle millions of accounts. That could...
The age of AI is upon us. A Chinese robot called “Lightning” just ran a half-marathon faster than any human...
AlphaStreet Newsdesk powered by AlphaStreet Intelligence Celsius Holdings plunged 7.3% on Monday to $29.93 as a trio of Wall Street...
May 07, 2026, 11:36 AM ETCanton Strategic Holdings, Inc. (CNTN) Stock, CC-USD Crypto, TCANMSFT, GS, NDAQ, DB, V, GSBD, MSFT:CA,...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
